Nasdaq Warns CombiMatrix of Failure to Meet Listing Requirement
July 02, 2012
Nasdaq Warns CombiMatrix of Failure to Meet Listing Requirement
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - CombiMatrix's Q1 Revenues Jump 27 Percent on Prenatal Microarray Testing Demand
May 8, 2013 / GenomeWeb Daily News - CombiMatrix to Raise $2.4M in Private Placement
May 6, 2013 / GenomeWeb Daily News - CombiMatrix Shares up Sharply as Firm Reports Record Prenatal Testing Volumes in Preliminary Q1 Results
April 4, 2013 / GenomeWeb Daily News - CombiMatrix to Raise $2M in Direct Offering
March 20, 2013 / GenomeWeb Daily News